Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pamlectabart is a humanised antibody targeting TNFRSF17/BCMA, which can be used to synthesise the antibody-drug conjugate (ADC) Pamlectabart tismanitin for the study of multiple myeloma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $249 | In Stock | |
5 mg | $747 | In Stock | |
10 mg | $1,200 | In Stock | |
25 mg | $1,995 | In Stock | |
50 mg | $2,990 | In Stock |
Description | Pamlectabart is a humanised antibody targeting TNFRSF17/BCMA, which can be used to synthesise the antibody-drug conjugate (ADC) Pamlectabart tismanitin for the study of multiple myeloma. |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.